Vault-13

XERIS BIOPHARMA HOLDINGS INC XERS 8 07.15.28

NOTE 8.000% 7/1 · US DOMESTIC · CUSIP 98422EAB9

2 institutional holders +0 vs Q1 2026
$33.6mprincipal reported held*
$91.4mreported value*
0 new 0 added 0 reduced 0 sold out net bought ≈ $0

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

024Q1 25: 4Q2 25: 3Q3 25: 2Q4 25: 2Q1 26: 2Q2 26: 22Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26
Numbers
QuarterHolders
Q1 20254
Q2 20253
Q3 20252
Q4 20252
Q1 20262
Q2 20262

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q2 25: 1 bought or addedQ2 25: 1 cut or sold outQ2 25Q3 25: 1 bought or addedQ3 25: 1 cut or sold outQ3 25Q4 25: 0 bought or addedQ4 25: 0 cut or sold outQ4 25Q1 26: 0 bought or addedQ1 26: 0 cut or sold outQ1 26Q2 26: 0 bought or addedQ2 26: 0 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q2 202511
Q3 202511
Q4 202500
Q1 202600
Q2 202600

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 CAPSTONE INVESTMENT ADVISORS, LLC 0.44% of their portfolio NEW YORK, NY 23,074,00023.1m $62.6m $62.6m 0.44% Unchanged
2 Polar Asset Management Partners Inc. 0.53% of their portfolio TORONTO, A6 10,500,00010.5m $28.8m $28.8m 0.53% Unchanged